Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function.
Saved in:
| Title: | Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function. |
|---|---|
| Authors: | Jenewein, Erin C. (AUTHOR), Cotter, Susan (AUTHOR), Roberts, Tawna (AUTHOR), Kulp, Marjean (AUTHOR), Mitchell, G. Lynn (AUTHOR), Jones‐Jordan, Lisa A. (AUTHOR), Chen, Angela M. (AUTHOR), Hopkins, Kristine (AUTHOR), Huang, Kristine (AUTHOR), Amster, Deborah (AUTHOR), Fecho, Gregory (AUTHOR), Tyler, Julie (AUTHOR), Meiyeppen, Shivakhaami (AUTHOR), Scheiman, Mitchell (AUTHOR), Cooper, Jeffrey (AUTHOR), Schulman, Erica (AUTHOR), Hamian, Kimberly (AUTHOR), Iacono, Danielle (AUTHOR), Larson, Steven (AUTHOR), Leung, Valerie (AUTHOR) |
| Source: | Ophthalmic & Physiological Optics. Jan2023, Vol. 43 Issue 1, p105-115. 11p. 4 Charts, 5 Graphs. |
| Subjects: | Intravenous therapy, Analysis of variance |
| Abstract: | Purpose: To evaluate the time course of improvements in clinical convergence measures for children with symptomatic convergence insufficiency treated with office‐based vergence/accommodative therapy. Methods: We evaluated convergence measures from 205, 9‐ to 14‐year‐old children with symptomatic convergence insufficiency randomised to office‐based vergence/accommodative therapy in the Convergence Insufficiency Treatment Trial – Attention and Reading Trial (CITT‐ART). Near‐point of convergence (NPC) and near‐positive fusional vergence (PFV) were measured at baseline and after 4, 8, 12 and 16 weeks of therapy; mean change in NPC and PFV between these time points were compared using repeated measures analysis of variance. Rates of change in NPC and PFV from: (1) baseline to 4 weeks and (2) 4–16 weeks were calculated. For each time point, the proportion of participants to first meet the normal criterion for NPC (<6 cm), PFV blur (break if no blur; >15Δ and >2 times the exodeviation) and convergence composite (NPC and PFV both normal) were calculated. Results: The greatest change in NPC and PFV (7.6 cm and 12.7 Δ) and the fastest rate of improvement in NPC and PFV (1.9 cm/week and 3.2 Δ/week, respectively) were both found during the first 4 weeks of therapy, with both slowing over the subsequent 12 weeks. After 12 weeks of therapy, the NPC, PFV and convergence composite were normal in 93.2%, 91.7% and 87.8% of participants, respectively, and normalised with another 4 weeks of therapy in 4.4%, 2.0% and 4.4% of participants, respectively. Conclusion: Although the greatest improvements in NPC and PFV occurred in the first 4 weeks of therapy, most participants had weekly improvements over the subsequent 12 weeks of treatment. While most children with convergence insufficiency obtained normal convergence following 12 weeks of therapy, an additional 4 weeks of vergence/accommodative therapy may be beneficial for some participants. [ABSTRACT FROM AUTHOR] |
| Copyright of Ophthalmic & Physiological Optics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 160718161 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Jenewein%2C+Erin+C%2E%22">Jenewein, Erin C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cotter%2C+Susan%22">Cotter, Susan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roberts%2C+Tawna%22">Roberts, Tawna</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kulp%2C+Marjean%22">Kulp, Marjean</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mitchell%2C+G%2E+Lynn%22">Mitchell, G. Lynn</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jones‐Jordan%2C+Lisa+A%2E%22">Jones‐Jordan, Lisa A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chen%2C+Angela+M%2E%22">Chen, Angela M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hopkins%2C+Kristine%22">Hopkins, Kristine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Kristine%22">Huang, Kristine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Amster%2C+Deborah%22">Amster, Deborah</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fecho%2C+Gregory%22">Fecho, Gregory</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tyler%2C+Julie%22">Tyler, Julie</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meiyeppen%2C+Shivakhaami%22">Meiyeppen, Shivakhaami</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Scheiman%2C+Mitchell%22">Scheiman, Mitchell</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cooper%2C+Jeffrey%22">Cooper, Jeffrey</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schulman%2C+Erica%22">Schulman, Erica</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hamian%2C+Kimberly%22">Hamian, Kimberly</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iacono%2C+Danielle%22">Iacono, Danielle</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Larson%2C+Steven%22">Larson, Steven</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leung%2C+Valerie%22">Leung, Valerie</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Ophthalmic+%26+Physiological+Optics%22">Ophthalmic & Physiological Optics</searchLink>. Jan2023, Vol. 43 Issue 1, p105-115. 11p. 4 Charts, 5 Graphs. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Intravenous+therapy%22">Intravenous therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Analysis+of+variance%22">Analysis of variance</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Purpose: To evaluate the time course of improvements in clinical convergence measures for children with symptomatic convergence insufficiency treated with office‐based vergence/accommodative therapy. Methods: We evaluated convergence measures from 205, 9‐ to 14‐year‐old children with symptomatic convergence insufficiency randomised to office‐based vergence/accommodative therapy in the Convergence Insufficiency Treatment Trial – Attention and Reading Trial (CITT‐ART). Near‐point of convergence (NPC) and near‐positive fusional vergence (PFV) were measured at baseline and after 4, 8, 12 and 16 weeks of therapy; mean change in NPC and PFV between these time points were compared using repeated measures analysis of variance. Rates of change in NPC and PFV from: (1) baseline to 4 weeks and (2) 4–16 weeks were calculated. For each time point, the proportion of participants to first meet the normal criterion for NPC (<6 cm), PFV blur (break if no blur; >15Δ and >2 times the exodeviation) and convergence composite (NPC and PFV both normal) were calculated. Results: The greatest change in NPC and PFV (7.6 cm and 12.7 Δ) and the fastest rate of improvement in NPC and PFV (1.9 cm/week and 3.2 Δ/week, respectively) were both found during the first 4 weeks of therapy, with both slowing over the subsequent 12 weeks. After 12 weeks of therapy, the NPC, PFV and convergence composite were normal in 93.2%, 91.7% and 87.8% of participants, respectively, and normalised with another 4 weeks of therapy in 4.4%, 2.0% and 4.4% of participants, respectively. Conclusion: Although the greatest improvements in NPC and PFV occurred in the first 4 weeks of therapy, most participants had weekly improvements over the subsequent 12 weeks of treatment. While most children with convergence insufficiency obtained normal convergence following 12 weeks of therapy, an additional 4 weeks of vergence/accommodative therapy may be beneficial for some participants. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Ophthalmic & Physiological Optics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=160718161 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/opo.13062 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 105 Subjects: – SubjectFull: Intravenous therapy Type: general – SubjectFull: Analysis of variance Type: general Titles: – TitleFull: Vergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jenewein, Erin C. – PersonEntity: Name: NameFull: Cotter, Susan – PersonEntity: Name: NameFull: Roberts, Tawna – PersonEntity: Name: NameFull: Kulp, Marjean – PersonEntity: Name: NameFull: Mitchell, G. Lynn – PersonEntity: Name: NameFull: Jones‐Jordan, Lisa A. – PersonEntity: Name: NameFull: Chen, Angela M. – PersonEntity: Name: NameFull: Hopkins, Kristine – PersonEntity: Name: NameFull: Huang, Kristine – PersonEntity: Name: NameFull: Amster, Deborah – PersonEntity: Name: NameFull: Fecho, Gregory – PersonEntity: Name: NameFull: Tyler, Julie – PersonEntity: Name: NameFull: Meiyeppen, Shivakhaami – PersonEntity: Name: NameFull: Scheiman, Mitchell – PersonEntity: Name: NameFull: Cooper, Jeffrey – PersonEntity: Name: NameFull: Schulman, Erica – PersonEntity: Name: NameFull: Hamian, Kimberly – PersonEntity: Name: NameFull: Iacono, Danielle – PersonEntity: Name: NameFull: Larson, Steven – PersonEntity: Name: NameFull: Leung, Valerie IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 02755408 Numbering: – Type: volume Value: 43 – Type: issue Value: 1 Titles: – TitleFull: Ophthalmic & Physiological Optics Type: main |
| ResultId | 1 |